SCHEMBL4599457

SCHEMBL4599457

CS(=O)(=O)Oc1cccc(OC(=O)N2CCOCC2)c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.66
EPHX1 P07099 2/20 0.62
RAB9A P51151 3/20 0.60
KMT2A Q03164 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
MEN1 O00255 2/20 0.60
SMN1; SMN2 Q16637 3/20 0.57
TSHR P16473 2/20 0.57
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
GAA P10253 1/20 0.53
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
TP53 P04637 1/20 0.51
POLB P06746 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA1 P30542 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599586 0.84 HSD17B10 (0.69) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL4598889 0.83 CYP1A2 (0.61) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL4599565 0.78 EPHX1 (0.68) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL28372646 0.78 EPHX1 (0.68) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL4599459 0.78 EPHX1 (0.68) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL4598628 0.78 EPHX1 (0.68) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL4197062 0.77 EPHX1 (1.00) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL5101418 0.77 KMT2A (0.82) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL9472899 0.75 RAB9A (0.62) HSD17B10EPHX1RAB9AKMT2ANPSR1
SCHEMBL29866129 0.75 AGXT (0.50) KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed